Secondary Prognostic Index in RefrActory Lymphoma

Clinical trial NCT04804865 · UNKNOWN

Trial details

NCT number: NCT04804865
Sponsor: Weprom
Status: UNKNOWN
Study type: OBSERVATIONAL

Diffuse Large B Cell Lymphoma Refractory Diffuse Large B-Cell Lymphoma

Start date: 2020-01-01
Primary completion: 2022-06-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.